Valuation: Novartis AG

Market Cap 295B 260B 242B 222B 417B 28,319B 422B 2,872B 1,122B 13,983B 1,109B 1,085B 48,331B P/E 2026 *
21.6x
P/E 2027 * 18.9x
Enterprise Value 328B 289B 269B 247B 463B 31,495B 470B 3,194B 1,248B 15,551B 1,233B 1,206B 53,751B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 5.29x
Free-Float
91.66%
Yield 2026 *
2.81%
Yield 2027 * 2.94%
1 day+1.80%
1 week+2.82%
Current month+1.53%
1 month+1.77%
3 months+13.03%
6 months+10.91%
Current year+17.26%
1 week 121.68
Extreme 121.68
129.4
1 month 121.06
Extreme 121.06
129.4
Current year 107.68
Extreme 107.68
131
1 year 91.56
Extreme 91.56
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.28%+2.82%+38.42%+43.21% 295B
+0.13%+4.41%+48.19%+163.20% 1,067B
+0.97%+6.88%+60.00%+53.12% 635B
-0.94%+1.39%+36.28%+72.60% 458B
+1.41%+7.75%+38.93%+32.88% 347B
+1.72%+2.33%+19.31%+20.79% 262B
+1.84%-1.03%-27.78%-38.45% 216B
+0.06%+3.32%+24.88%+59.40% 203B
+0.94%-2.02%+15.47%+70.59% 161B
+0.53%-0.32%+1.48%-31.85% 140B
Average +1.22%+0.99%+25.52%+44.55% 378.34B
Weighted average by Cap. +0.93%+1.80%+36.41%+74.35%

Financials

2026 *2027 *
Net sales 57.55B 50.59B 47.1B 43.25B 81.22B 5,519B 82.29B 560B 219B 2,725B 216B 211B 9,419B 61.09B 53.71B 50B 45.91B 86.22B 5,859B 87.35B 594B 232B 2,893B 229B 224B 9,999B
Net income 13.94B 12.25B 11.4B 10.47B 19.67B 1,337B 19.93B 136B 52.95B 660B 52.32B 51.19B 2,281B 15.34B 13.49B 12.56B 11.53B 21.65B 1,471B 21.94B 149B 58.29B 727B 57.59B 56.35B 2,511B
Net Debt 33.11B 29.11B 27.1B 24.89B 46.73B 3,176B 47.35B 322B 126B 1,568B 124B 122B 5,420B 27.82B 24.45B 22.76B 20.91B 39.26B 2,668B 39.77B 271B 106B 1,317B 104B 102B 4,553B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
27/07/26 CHF 128.52 +1.28% 2,435,055
24/07/26 CHF 126.90 -0.60% 1,859,367
23/07/26 CHF 127.66 +1.85% 2,482,939
22/07/26 CHF 125.34 -0.16% 2,648,334
21/07/26 CHF 125.54 +1.98% 3,462,607
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.36USD
Average target price
154.07USD
Spread / Average Target
-0.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock